Related Experiment Video
Updated: Dec 3, 2025

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Prevalence of the prothrombin G20210A mutation among ischemic stroke patients
Salar A Ahmed1, Sazgar A Hameed2, Bashdar M Hussen3
1Department of Clinical Biochemistry, College of Medicine, Hawler Medical University, Erbil, Iraq.
Abstract:
Ischemic stroke is characterized as a sudden neurological deficit attributed to an acute focal injury of the central nervous system by a vascular cause. This study was performed to determine the frequency of G20210A mutation in the prothrombin gene and its effectiveness on the incidence of ischemic stroke in the Erbil city of Kurdistan region, Iraq. A total of 50 patients with ischemic stroke was analyzed for the detection of prothrombin gene mutation (G20210A), using polymerase chain reaction (PCR), Restriction fragment length polymorphism (RFLP) with Hind III restriction enzyme. We observed no evidence of an association between ischemic stroke and G20210A mutation in the prothrombin gene in this region. Our finding demonstrates that prothrombotic gene variant seems not to be linked to the incidence of ischemic stroke in Erbil region.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

